Prime Medicine Expands Leadership Team with Key Appointments to Support Continued Growth and Advancement of Prime Editing Technology and Portfolio
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prime Medicine, Inc. (“Prime Medicine”), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying Prime Editing technology, today announced the expansion of the company’s leadership team with the appointments of the following executives: Richard Brudnick as … [Read more…]
